American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Cannabis Bioscience International Holdings, Inc. (CBIH)

$0.00 +0.00% OTC: CBIH · 15-min delayed

HOUSTON, Texas
Public · OTC: CBIH

Visit website Follow

$303.0KRevenue · FY2025

-$548.8KNet income

CBIHOTC

About Cannabis Bioscience International Holdings, Inc.

CANNABIS BIOSCI INTL HLDG

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: CBIH
Headquarters: HOUSTON, Texas
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: CBIH OTC
SEC CIK: 1411057
EIN: 844901229
SIC: 8731 Services-Commercial Physical & Biological Research

Embed this company’s badge

Show Cannabis Bioscience International Holdings, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/cannabis-bioscience-international-holdings-inc/"><img src="https://americancompanies.com/badge/cannabis-bioscience-international-holdings-inc.svg" alt="Cannabis Bioscience International Holdings, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Cannabis Bioscience International Holdings, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $303.0K
Net income: -$548.8K
Total assets: $31.9K

Source: SEC EDGAR · updated Jun 7, 2026

OTC: CBIH

$0.00 +0.00%

15-minute delayed · data by Polygon.io

Past year · hover for prices

Open: —
Day range: –
Prev close: —
Volume: —

Cannabis Bioscience International Holdings, Inc. (CBIH) Stock Price

Reported a net loss of $548.8K in FY2025.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Cannabis Bioscience International Holdings, Inc..

Write a review

Newsroom

News about Cannabis Bioscience International Holdings, Inc.

Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now GlobeNewswire Inc. · 2025-01-15 · positive CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications - GlobeNewswire GlobeNewswire Inc. · 2024-07-15 · positive CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change GlobeNewswire Inc. · 2024-06-26 Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation GlobeNewswire Inc. · 2024-06-17 CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward GlobeNewswire Inc. · 2024-06-05

News & sentiment via Polygon.io

FAQ

Cannabis Bioscience International Holdings, Inc.: frequently asked questions

Is Cannabis Bioscience International Holdings, Inc. an American company?

Cannabis Bioscience International Holdings, Inc. is a US-based company headquartered in Houston, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Cannabis Bioscience International Holdings, Inc. headquartered?

Cannabis Bioscience International Holdings, Inc. is headquartered in Houston, Texas, United States.

Is Cannabis Bioscience International Holdings, Inc. publicly traded?

Yes — Cannabis Bioscience International Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol CBIH on the OTC.

What does Cannabis Bioscience International Holdings, Inc. do?

Cannabis Bioscience International Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore